2025年
原著
-
"The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis."
Kanda M, Nagahata K, Moriyama M, Takano KI, Kamekura R, Yoshifuji H, Tsuboi H, Yamamoto M, Umehara H, Umeda M, Sakamoto M, Maehara T, Inoue Y, Kubo S, Himi T, Origuchi T, Masaki Y, Mimori T, Dobashi H, Tanaka Y, Nakamura S, Takahashi H and Japanese Study Group for IgG4-related Dacryoadenitis and Sialadenitis, Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW), Japan.
Mod Rheumatol. 35, 3, 542-547 (2025).
-
総説
-
"Recent evidence of the role of CD4+ T cell subsets in IgG4-related disease."
Kamekura R, Sakamoto H, Yajima R, Yamamoto K, Okuni T, Yamamoto M, Takahashi H, Ichimiya S, Takano K.
JMA J. 8, 1, 40-47 (2025).
学会・研究会発表
2024年
原著
-
-
-
"GWAS for systemic sclerosis identified six novel 1 susceptibility loci including one in the Fcγ receptor region."
83. Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, Hasegawa M, Matsushita T, Saito K, Motegi S, Yoshifuji H, Yoshizaki A, Kohmoto T, Takagi K, Oka A, Kanda M, Tanaka Y, Ito Y, Nakano K, Kasamatsu H, Utsunomiya A, Sekiguchi A, Niiro H, Jinnin M, Makino K, Makino T, Ihn H, Yamamoto M, Suzuki C, Takahashi H, Nishida E, Morita A, Yamamoto T, Fujimoto M, Kondo Y, Goto D, Sumida T, Ayuzawa N, Yanagida H, Horita T, Atsumi T, Endo H, Shima Y, Kumanogoh A, Hirata J, Otomo N, Suetsugu H, Koike Y, Tomizuka K, Yoshino S, Liu X, Ito S, Hikino K, Suzuki A, Momozawa Y, Ikegawa S, Tanaka Y, Ishikawa O, Takehara K, Torii T, Sato S, Okada Y, Mimori T, Matsuda F, Matsuda K, Amariuta T, Imoto I, Matsuo K, Kuwana M, Kawaguchi Y, Ohmura K, Terao C
Nat Commun. 15, 1, 319 (2024).
-
総説
講演
学会・研究会発表
その他
症例報告
2023年
原著
-
"The crucial role of muscle glucocorticoid signaling in accelerating obesity and glucose intolerance via hyperinsulinemia"
Yamazaki H, Uehara M, Yoshikawa N, Kuribara-Souta A, Yamamoto M, Hirakawa Y, Kabe Y, Suematsu M, Tanaka T
JCI Insight 8, 8, e162382 (2023).
総説
講演
学会・研究会発表
症例報告
2022年
原著
-
-
"CD4(+)CD8(+) T follicular helper cells regulate humoral immunity in chronic inflammation lesions."
Murayama K, Ikegami I, Kamekura R, Sakamoto H, Yagagi M, Kamiya S, Sato T, Sato A, Shigehara K, Yamamoto M, Takahashi H, Takano KI, Ichimiya S.
Front Immunol. 13, 941385 (2022).
-
"Nationwide Epidemiological survey of IgG4-related disease with malignancy in Japan."
Sumitomo K, Uchida K, Ikeura T, Hirano K, Yamamoto M, Takahashi H, Nishino T, Mizushima I, Kawano M, Kamisawa T, Saeki T, Maguchi H, Ushijima T, Shiokawa M, Seno H, Goto H, Nakamura S, Okazaki K, the Research Committee for an Intractable Disease of IgG4-related disease.
J Gastroenterol Hepatol. 37, 6, 1022-1033 (2022).
-
"The differential diagnosis of IgG4related disease based on machine learning."
Yamamoto M, Nojima M, Kamekura R, Kuribara-Souta A, Uehara M, Yamazaki H, Yoshikawa N, Aochi S, Mizushima I, Watanabe T, Nishiwaki A, Komai T, Shoda H, Kitagori K, Yoshifuji H, Hamano H, Kawano M, Takano K, Fujio K, Tanaka H.
Arthritis Res Ther. 24, 71 (2022).
総説
講演
学会・研究会発表
-
-
-
-
-
-
-
"The ever-largest Asian GWAS for Systemic Sclerosis and trans-population meta-analysis identified seven novel loci and a candidate causal SNP in a cis-regulatory element of the FCGR region."
Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, Hasegawa M, Matsushita T, Kazuyoshi S, Motegi S, Yoshifuji H, Yoshizaki A, Kohmoto T, Takagi K, Oka A, Kanda M, Tanaka Y, Ito Y, Nakano K, Kasamatsu H, Utsunomiya A, Sekiguchi A, Niro H, Jinnin M, Makino K, Makino T, Ihn H, Yamamoto M, Suzuki C, Takahashi H, Nishida E, Morita A, Yamamoto T, Fujimoto M, Kondo Y, Goto D, Sumida T, Ayuzawa N, Yanagida H, Horita T, Atsumi T, Endo H, Shima Y, Kumanogoh A, Hirata J, Otomo N, Suetsugu H, Koike Y, Tomizuka K, Yoshino S, Liu X, Ito S, Hikino K, Suzuki A, Momozawa Y, Ikegawa S, Tanaka Y, Ishikawa O, Takehara K, Torii T, Sato S, Okada Y, Mimori T, Matsuda F, Matsuda K, Imoto I, Matsuo K, Kuwana M, Kawaguchi Y, Ohmura K, Terao C.
EULAR 2022, Copenhagen, Denmark /WEB配信 (2022).
-
-
その他
受賞
症例報告
2021年
原著
-
"Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial. "
Yuki Y, Nojima M, Hosono O, Tanaka H, Kimura Y, Satoh T, Imoto S, Uematsu S, Kurokawa S, Kashima K, Mejima M, Nakahashi-Ouchida R, Uchida Y, Marui T, Yoshikawa N, Nagamura F, Fujihashi K, Kiyono H
Lancet Microbe. 2, 9, e429-440 (2021).
-
-
総説
講演
学会・研究会発表
その他
